Monografie
Analysis of circadian regulation in a cellular model of pancreatic cancer
- Sprache
-
Englisch
- Identifier
-
1234983869
Thema
Cancer
Beteiligte Personen und Organisationen
Li, Yin
- DOI
-
10.17169/refubium-29980
- URN
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
26.01.20242024, 13:53 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Monografie
Beteiligte
- Li, Yin
Ähnliche Objekte (12)
Pancreatic cancer
Pancreatic cancer
Modulating cellular plasticity of pancreatic cancer-associated fibroblasts driven by Prrx1
Exocrine pancreatic cancer
Dexamethasone-induced microRNA regulation of pancreatic cancer progression
Oncogenic KRAS supports pancreatic cancer through regulation of nucleotide synthesis
Chemoresistance in Pancreatic Cancer
Erlotinib in pancreatic cancer
Regulation of cellular dormancy in disseminated breast cancer cells
Posttranscriptional regulation in the circadian system
Metabolic derangements in pancreatic cancer
Metabolic Derangements in Pancreatic Cancer
Pancreatic cancer
Pancreatic cancer
Modulating cellular plasticity of pancreatic cancer-associated fibroblasts driven by Prrx1
Exocrine pancreatic cancer
Dexamethasone-induced microRNA regulation of pancreatic cancer progression
Oncogenic KRAS supports pancreatic cancer through regulation of nucleotide synthesis
Chemoresistance in Pancreatic Cancer
Erlotinib in pancreatic cancer
Regulation of cellular dormancy in disseminated breast cancer cells
Posttranscriptional regulation in the circadian system
Metabolic derangements in pancreatic cancer
Metabolic Derangements in Pancreatic Cancer
Pancreatic cancer
Pancreatic cancer
Modulating cellular plasticity of pancreatic cancer-associated fibroblasts driven by Prrx1
Exocrine pancreatic cancer
Dexamethasone-induced microRNA regulation of pancreatic cancer progression
Oncogenic KRAS supports pancreatic cancer through regulation of nucleotide synthesis
Chemoresistance in Pancreatic Cancer
Erlotinib in pancreatic cancer
Regulation of cellular dormancy in disseminated breast cancer cells
Posttranscriptional regulation in the circadian system
Metabolic derangements in pancreatic cancer